Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study

By E. Glatstein, M. Morrow. 2006

638 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f0a64620844e82ee75826e74e09cc92a570dd076

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

Citations in the corpus

Physical and psychological long‐term and late effects of cancer (2008, background): “but worsen in urinary incontinence and sexual function.(23,24) Perhaps because myeloablative hematopoietic stem cell transplant (HSCT) provides chemotherapy at very high doses and is used on some of the young-”
From cancer patient to cancer survivor : lost in transition (2006, background): “The Prostate Cancer Outcomes Study examined health and quality of life outcomes after prostatectomy or radiotherapy for prostate cancer (Potosky et al., 2000; Potosky et al., 2004; Johnson et al., 2004).”
Modeling recovery curves with application to prostatectomy. (2015, methodology): “The only longitudinal model we found in the literature was one using linear regression to relate the change in function level between two fixed timepoints after treatment (Potosky et al., 2004).”
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer (2013, methodology): “The cutoff point of 80 was chosen because it had previously been used in the 2- and 5-year PCOS reports of functional outcomes.8,9 This threshold was originally chosen on the basis of empirical assessment and the investigators’ judgment of clinical relevance.”
Guideline for the management of clinically localized prostate cancer: 2007 update. (2007, background): “Gradual physiologic loss of erections over time with active surveillance is expected, and a loss of function over time after radiotherapy also has been described.(75) Single-point estimates of function provide overly simplistic descriptions of a complex outcome and do not incorporate patientweighted”
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 (2018, neutral): “Hodgkin lymphoma 73 (66-82) 45 (40-54) 28 (25-32) 1.”